| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0032 | 1 |